Alvotech Starts European Trial For High-Concentration Adalimumab

 
• By Aidan Fry
  
HeadStatue
Alvotech is studying in plaque psoriasis patients its biosimilar of AbbVie's high-concentration version of Humira • Source: Shutterstock

More from Biosimilars

More from Products